Results 41 to 50 of about 32,822 (166)

Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report

JA Clinical Reports, 2019
Background Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial ...
Eriko Takeyama, Aiko Wada, Eizo Amano, Hiromi Shibuya   +3 more
doaj   +1 more source

The Case for Routine Genotyping in Dual-Antiplatelet Therapy

Journal of the American College of Cardiology, 2010
Over 1 million coronary stent procedures are performed annually in the U.S., with dual-antiplatelet therapy, which includes the use of both aspirin and clopidogrel, being a cornerstone in the management of these patients after coronary intervention. Now, recent data have surfaced demonstrating altered active metabolite levels of clopidogrel in patients
Damani, Samir B., Topol, Eric J.
openaire   +2 more sources

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

Frontiers in Cardiovascular Medicine, 2022
Dual antiplatelet therapy (DAPT) for 6–12 months, followed by lifelong aspirin monotherapy is considered an effective standard therapy for the prevention of thrombo-ischemic events in patients with acute and chronic coronary syndrome (ACS, CCS ...
Marie Muthspiel, Christoph C. Kaufmann, Achim Leo Burger, Benjamin Panzer, Freek W. A. Verheugt, Kurt Huber, Kurt Huber   +6 more
doaj   +1 more source

Clinical evaluation of role of dual antiplatelet therapy on bleeding after dental extraction

Contemporary Clinical Dentistry, 2018
Aims and Objectives: Altered platelet function and increased bleeding time (BT) can occur with antiplatelet therapy. This study was conducted to evaluate the need for stoppage of dual antiplatelet therapy in patients undergoing dental extractions ...
Prashant Babaji, Yousef Rishal
doaj   +1 more source

Dual Antiplatelet Therapy and Bleeding-Related Deaths

Journal of the American College of Cardiology, 2017
We read with interest the report by Palmerini et al. [(1)][1], who found that the risk of death from bleeding was related to the duration of dual antiplatelet therapy (DAPT), but we have questions about separating DAPT duration into the customary binary categories of “short” versus “long.”
John A, Bittl, Yulei, He
openaire   +2 more sources

Dual antiplatelet therapy in stroke and ICAS [PDF]

Neurology, 2015
AB OBJECTIVE: We aimed to investigate whether the efficacy and safety of clopidogrel plus aspirin vs aspirin alone were consistent between patients with and without intracranial arterial stenosis (ICAS), in the Clopidogrel in High-Risk Patients with Acute Non-disabling Cerebrovascular Events (CHANCE) trial.We assessed the interaction of the treatment ...
Liping Liu, Ka Sing Lawrence Wong, Xinyi Leng, Yuehua Pu, Yilong Wang, Jing Jing, Xinying Zou, Yuesong Pan, Anxin Wang, Xia Meng, Chunxue Wang, Xingquan Zhao, Yannie Soo, S. Claiborne Johnston, Yongjun Wang, Zhimin Wang, Yongjun Wang, Haiqin Xia, Bin Li, Guiru Zhang, Xudong Ren, Chunling Ji, Guohua Zhang, Jianhua Li, Bohua Lu, Liping Wang, Shutao Feng, Dali Wang, Weiguo Tang, Juntao Li, Hongtian Zhang, Guanglai Li, Baojun Wang, Yuhua Chen, Ying Lian, Bin Liu, Junfang Teng, Rubo Sui, Lejun Li, Zhiling Yuan, Dawei Zang, Zuneng Lu, Li Sun, Dong Wang, Liying Hou, Dongcai Yuan, Yongliang Cao, Hui Li, Xiuge Tan, Huicong Wang, Haisong Du, Mingyi Liu, Suping Wang, Qiuwu Liu, Zhong Zhang, Qifu Cui, Runqing Wang, Jialin Zhao, Jiewen Zhang, Jianping Zhao, Qi Bi, Xiyou Qi, Junyan Liu, Changxin Li, Ling/Lv Li, Xiaoping Pan, Junling Zhang, Derang Jiao, Zhao Han, Dawei Qian, Jin Xiao, Yan Xing, Huishan Du, Guang Huang, Yongqiang Cui, Yan Li, Lianyuan Feng, Lianbo Gao, Bo Xiao, Yibin Cao, Yiping Wu, Jinfeng Liu, Zhiming Zhang, Zhengxie Dong, Limin Wang, Li He, Xinchen Wang, Xueying Guo, Ming Wang, Xiaosha Wang, Jiandong Jiang, Renliang Zhao, Shengnian Zhou, Hao Hu, Maolin He, Fengchun Yu, Quping Ouyang, Jingbo Zhang, Anding Xu, Xiaokun Qi, Lei Wang, Fuming Shi, Fuqiang Guo, Jianfeng Wang, Fengli Zhao, Ronghua Dou, Dongning Wei, Qingwei Meng, Yilu Xia, Shimin Wang, Zhangcang Xue, Yuming Xu, Liping Ma, Chun Wang, Jiang Wu, Yifeng Du, Yinzhou Wang, Lijun Xiao, Fucong Song, Wenli Hu, Zhigang Chen, Qingrui Liu, Jiemin Zhang, Mei Chen, Xiaodong Yuan, Zhihui Liu, Guozhong Li, Xiaohong Li, Tingchen Tian   +128 more
openaire   +2 more sources

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?

Российский кардиологический журнал, 2014
The review provides the current information about the role of antiplatelet therapy in the cardiovascular prevention in patients with coronary artery disease and coronary revascularization.
Yu. I. Grinschtein, A. A. Kosinova, I. Yu. Grinschtein   +2 more
doaj   +1 more source

The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy

Current Opinion in Neurology, 2020
Purpose of review Single antiplatelet therapy represents an established treatment in secondary prevention of ischemic strokes and transient ischemic attacks (TIAs). In contrast with coronary artery disease, the use of dual antiplatelet therapy (DAPT) for secondary prevention in patients with acute cerebral ischemia (ACI ...
Kargiotis, O., Tsivgoulis, G.
openaire   +3 more sources

Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients

Scientific Reports, 2017
The study aimed to evaluate whether the benefits of dual antiplatelet therapy would be influenced by blood pressure (BP) levels, among acute minor stroke or transient ischemic attack (TIA).
Jie Xu, Yongli Tao, Hao Li, Hongqiu Gu, Xuewei Xie, Xia Meng, Yuming Xu, Yilong Wang, Yongjun Wang   +8 more
doaj   +1 more source

The SAFEST Study: Survey on Antiplatelets in Flow Diversion for Aneurysm Endovascular Treatment

Stroke: Vascular and Interventional Neurology
Background Flow diversion has emerged as a promising treatment strategy for intracranial aneurysms, yet the influence of antiplatelet therapy on treatment outcomes remains uncertain. Regional and institutional variability in antiplatelet regimens further
Sophia Hohenstatt, Dominik F. Vollherbst, Thanh N. Nguyen, Zhongrong Miao, Mai Duy Ton, Hiroshi Yamagami, Adam A. Dmytriw, Gabriele Maliandi, Martin Bendszus, Jessica Jesser, Markus A. Möhlenbruch   +10 more
doaj   +1 more source